Fresh Rounds

Spine BioPharma, Inc. funding

Spine BioPharma, Inc., a pharmaceuticals company based in New York, NY, filed a Form D with the SEC on June 5, 2026 and reported $385K raised of a $8.5M offering.

Amount raised$385K
Offering size$8.5M
Filed with the SECJune 5, 2026
First saleMay 22, 2026
IndustryPharmaceuticals
SecuritiesEquity
LocationNew York, NY
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far3
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in New York